MedTrace Logo

Efficacy Evaluation of Hydrolyzed Collagen Peptide on Knees, Hips, and Ankle Pain in Osteoarthritis

NCT05369780 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2022-05-11

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness of Hydrolyzed collagen peptides on joint pain, stiffness and physical function in adults with osteoarthritis who have complaints on knee joints together with hip and ankles. The assessment of improvements on volunteers' quality of life, and safety and tolerability of the product is the other objective of this placebo-controlled, randomized study.

Conditions

  • Pain, Joint

Interventions

DIETARY_SUPPLEMENT

Hydrolyzed Collagen Peptide

Dietary Hydrolized Collagen Peptide sourced from bovine

Sponsors & Collaborators

  • Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.

    collaborator UNKNOWN

  • Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2023-05-15
Completion
2023-05-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05369780 on ClinicalTrials.gov